Cardiac biomarkers stand as crucial elements in the landscape of cardiovascular medicine, providing indispensable information about heart health. These biomarkers, often identifiable proteins released into the bloodstream in response to specific cardiac events, are instrumental in the diagnosis, prognosis, and ongoing monitoring of various cardiovascular conditions. While troponins, creatine kinase-MB (CK-MB), and B-type natriuretic peptide (BNP) remain prominent players in this domain, ongoing research strives to unveil new biomarkers that can offer even more nuanced insights into heart function. The continuous evolution of cardiac biomarker research contributes to a deeper understanding of cardiovascular diseases, paving the way for innovative diagnostic tools and personalized treatment approaches. As healthcare professionals delve into expanding the repertoire of cardiac biomarkers, they aim to enhance the precision of diagnoses and ultimately improve patient outcomes in the realm of cardiovascular care.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt